Rheumatology Advance Access originally published online on May 18, 2004
Rheumatology 2004 43(8):1000-1006; doi:10.1093/rheumatology/keh216
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Rheumatology Vol. 43 No. 8 © British Society for Rheumatology 2004; all rights reserved
Paper |
Transitional care for adolescents with juvenile idiopathic arthritis: a Delphi study
Institute of Child Health, University of Birmingham, Birmingham, UK.
Correspondence to: J. E. McDonagh, Institute of Child Health, Diana, Princess of Wales Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, UK. E-mail: j.e.mcdonagh{at}bham.ac.uk
Objective. To identify the ideal programme of transitional care for adolescents with juvenile idiopathic arthritis (JIA) as perceived by users and providers, and to examine the feasibility of achieving this within a UK National Health Service context.
Methods. A modified two-stage Delphi study was undertaken with rheumatology health professionals, young people with JIA (aged 1225 yr) and their parents. Participants were presented with statements about transitional care and asked to rate (i) the extent to which these constituted best practice, and (ii) their feasibility.
Results. Second-round questionnaires were completed by 83 individuals, representing an overall response rate of 90%. Items strongly agreed to constitute best practice and highly feasible included: addressing young people's psychosocial and educational/vocational needs; using an individualized approach; providing honest explanations of the adolescent's condition and health-care; providing opportunities for adolescents to express opinions and make informed decisions; having continuity in health personnel; and giving adolescents the option of being seen by professionals without their parents. However, providing adolescent-focused environments, professionals knowledgeable in transitional care and opportunities for young people with JIA to meet similar others were seen as feasible in only a few hospitals.
Conclusions. There is considerable agreement as to the most important elements of transitional care. Those that are easily achievable should be undertaken in all hospitals that care for adolescents with JIA. However, not all elements identified were perceived as easily feasible; further research is required to determine how to implement these elements.
KEY WORDS: Juvenile idiopathic arthritis, Adolescence, Transition, Delphi analysis
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
J. E McDonagh Transition of care from paediatric to adult rheumatology Arch. Dis. Child., September 1, 2007; 92(9): 802 - 807. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. McDonagh, T. R. Southwood, K. L. Shaw, and on behalf of the British Society of Paediatric and The impact of a coordinated transitional care programme on adolescents with juvenile idiopathic arthritis Rheumatology, January 1, 2007; 46(1): 161 - 168. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. McDonagh, K. L. Shaw, and T. R. Southwood Growing up and moving on in rheumatology: development and preliminary evaluation of a transitional care programme for a multicentre cohort of adolescents with juvenile idiopathic arthritis J Child Health Care, March 1, 2006; 10(1): 22 - 42. [Abstract] [PDF] |
||||
![]() |
L P Robertson, J E McDonagh, T R Southwood, K L Shaw, and on behalf of the British Society of Paediatric and Growing up and moving on. A multicentre UK audit of the transfer of adolescents with juvenile idiopathic arthritis from paediatric to adult centred care Ann Rheum Dis, January 1, 2006; 65(1): 74 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Shaw, T. R. Southwood, J. E. McDonagh, and on behalf of the British Society of Paediatric and Growing up and moving on in rheumatology: a multicentre cohort of adolescents with juvenile idiopathic arthritis Rheumatology, June 1, 2005; 44(6): 806 - 812. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Wedderburn, P. Woo, and R. G. Hull Paediatric rheumatology: a bright future in the UK and Europe Rheumatology, April 1, 2005; 44(4): 423 - 425. [Full Text] [PDF] |
||||



